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 Summary
  Multiparametric MRI of the prostate gland is a relatively new diagnostic modality which is 
gathering a growing interest among urologists and radiologists. The second version of the 
PI-RADS guidelines enabled standardized imaging, evaluation and reporting of prostatic lesions. 
Nonetheless, since 2015 – when the PI-RADS v.2 was published, numerous questions regarding 
imaging of the prostate gland have appeared.
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In January 2017, I had a pleasure to visit Radboud 
University Medical Centre (RUNMC) in Nijmegen, Holland 
which is a world-leading center for prostate imaging and 
research. I met professor Jelle Barentsz, who is the main 
author of PI-RADS [1], a professor of radiology, and Chair 
of a research department at RUNMC. Professor Barentsz 
heads also a worldwide network of MRI providers accred-
ited by the Prostate Centres of Excellence (COE), which was 
also developed at RUNMC. It is an imaging team of radiolo-
gists and technicians trained in Holland by Prof. Barentsz 
and his team in the application of the RUNMC imaging 
protocol. Apart from that, during the course, participants 
are trained to produce structured reports that include key 
images and multiparametric data which are integrated 
with the written assessment of the radiologist.
Although the general principles of imaging used in 
Nijmegen are similar to those applied in Poland, there 
are also significant differences which drew my atten-
tion. The patients are examined on a 3T scanner without 
an endorectal coil. The minimal protocol (including T2W 
images in three planes, DWI and ADC maps, k-trans con-
trast enhancement) is applied for diagnostic purposes. On 
the other hand spectroscopy is used primarily for scientific 
purposes. Strong confidence is put on ADC values, although 
the reporting team bears in mind that the values may differ 
between scanners. Such a short protocol enables perform-
ing the imaging within 30 minutes. However, if there is a 
suspicion of prostate cancer based on diagnostic prostate 
MRI, the patient undergoes MRI-guided biopsy within a 
couple of days. If there is a need to exclude distal metas-
tases, PET-CT or whole-body MRI with a special contrast 
agent that is highly specific for prostate cancer [2] is per-
formed without delay. In general, the whole diagnostic 
evaluation with establishment of further treatment can be 
performed within a week.
Clinical meetings with urologists, radiologists, radiother-
apists, oncologists, and pathologists take place weekly. 
Each participant is encouraged to share his or her opinion 
regardless of specialty. Apart from that, there are separate 
meetings for radiologists and technicians who perform 
MRI-guided biopsies. Such a close cooperation between 
team members significantly improves confidence of their 
diagnostic and therapeutic decisions. It also has a positive 
impact on patients’ quality of life.
Another advantage of such a close cooperation is a possibil-
ity of implementation of multiparametric MRI of the pros-
tate gland as a screening method, along with PSA evalua-
tion. A new short protocol might possibly serve as a relia-
ble tool to select men who may benefit from early detection 
and prostate biopsy. Such a protocol has a reduced dura-
tion of imaging (approximately 15 minutes), and it does 
not involve routine contrast administration. Doubtlessly, it 
would enable more accurate diagnosis in a much shorter 
time without the need of repetitive TRUS-biopsies..
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A growing interest in multiparametric imaging of the pros-
tate gland is justified, since there is no better tool for imag-
ing of prostate cancer [3,4]. However, it must be kept in 
mind that new solutions are being constantly implemented 
in terms of diagnosis and treatment, and a close coopera-
tion between specialties is essential to improve medical 
care.
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